The latest happenings in the industry, all in one place.
Ergomed plc announced the appointment of Lewis Cameron as Chief Operating Officer and to the Board.
CTI Clinical Trial and Consulting Services has announced the additions of Savannah Doliboa and Nick Finan to the Business Development department and Rochelle Maher to the Regulatory & Scientific Affairs department. They also announced the promotions of Ana Patacão to Executive Director, Real World Evidence & Late Phase, and Brian Johnston to Senior Director, Clinical Project Management.
LaRee Tracy
PHASTAR announced the hiring of LaRee Tracy, PhD, as Director of Biostatistics.
Spaulding Clinical Research has announced that it has named Cassandra Erato Chief Executive Officer.
Syntactx announced that Dorothy Abel has joined the company as Vice President, Regulatory Strategy.
Continuum Clinical has announced Paul Ivsin as the new Vice President of Data and Analytics.
Clinerion and Datametrix partner to deliver Real World Evidence insights from Real World Data from Clinerion’s global hospital network.
In 2019, AG Mednet realized more than 35 percent growth both in revenue and new product sales, and nearly 40 percent growth in average deal-value.
Nebraska Innovation Campus has announced Celerion will move into a space on the campus.
Veeva Systems announced that an increasing number of life sciences companies are adopting applications in the Veeva Vault RIM Suite to streamline regulatory information management.
PHASTAR announced that the company has chosen San Diego as the site for its new U.S. West Coast office.
Novotech has won the Australian-Korean Business Awards 2020 - Award for Excellence, in the category Biotech and Health.
Advanced Clinical has been recognized by ClearlyRated, earning the Best of Staffing Client and Talent Awards for the fifth consecutive year.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.